WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2014> 25> 2

Volume: 25 Issue: 2

1. Surgery or chemoradiation for stage IB cervical cancer? How cost effectiveness impacts a complex decision. Page:79—80
2. Creating and field-testing the questionnaire for the assessment of knowledge about cervical cancer and its prevention among schoolgirls and female students. Page:81—89
3. The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage I/II uterine cervical cancer. Page:90—96
4. Cost-utility analysis of treatments for stage IB cervical cancer. Page:97—104
5. Survival analysis of endometrial cancer patients with cervical stromal involvement. Page:105—110
6. Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes. Page:111—117
7. Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women. Page:118—123
8. Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan. Page:124—129
9. Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer. Page:130—135
10. Adjuvant therapy for endometrial cancer. Page:136—147
11. Building a successful fertility preservation program at a major cancer center. Page:148—154
12. Consideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancer. Page:155—155
13. Book Review: Primary, secondary, and tertiary prevention of cervical cancer. Page:157—158

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.